CLINICAL_TRIALS
trial_result
· 2020-03-23
Clinical Trial Update: Fimasartan in the Senior Subjects [Phase 3]
Summary
Phase 3 trial update for fimasartan in elderly subjects (≥70) with essential hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: The Elderly (≥ 70 Years) With Essential Hypertension | Phase 3 | Status: COMPLETED